BFEC
DTIL icon

Benjamin F. Edwards & Company’s Precision BioSciences DTIL Stock Holding History

Benjamin F. Edwards & Company’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17
Closed -$4K – 1682
2020
Q4 		$4K Hold
17
– – ﹤0.01% 1441
2020
Q3 		$3K Hold
17
– – ﹤0.01% 1510
2020
Q2 		$4K Hold
17
– – ﹤0.01% 1468
2020
Q1 		$3K Hold
17
– – ﹤0.01% 1525
2019
Q4 		$7K Hold
17
– – ﹤0.01% 1507
2019
Q3 		$4K Hold
17
– – ﹤0.01% 1616
2019
Q2 		$7K Buy
+17
New +$6.84K ﹤0.01% 1514

Other funds holding DTIL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Benjamin F. Edwards & Company's DTIL Position: Q1 2021 in Review

Benjamin F. Edwards & Company sold out of Precision BioSciences (DTIL) in Q1 2021, closing a stake of 17 shares — an estimated $4K sold.

Benjamin F. Edwards & Company first reported a position in DTIL in Q2 2019 and held it in 7 quarters. The position peaked at $7K in Q4 2019. 128 funds tracked by Wall St. Rank hold DTIL as of Q1 2021.

  • Benjamin F. Edwards & Company reported no remaining Precision BioSciences position as of Q1 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 17 Precision BioSciences shares in Q1 2021, an estimated $4K.
  • Benjamin F. Edwards & Company first reported a position in Precision BioSciences in Q2 2019 and held it in 7 quarters.
  • Benjamin F. Edwards & Company's Precision BioSciences position peaked at $7K in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2021, filed 14 May 2021.